Microbial Collagenase: all 70 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)Not yet recruitingNCT07846280Phase 3
• Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingNCT07759362Phase 3
• Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar FibromatosisCompletedNCT05152173Phase 2Results posted
• CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection TechniquesCompletedNCT04580303Phase 2Results posted
• Safety and Efficacy of EN3835 in Participants With Frozen ShoulderCompletedNCT04496167Phase 2Results posted
• Histopathology Following CCH InjectionCompletedNCT04236635Phase 2Results posted
• Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult WomenTerminatedNCT04209530Phase 2Results posted
• Real World CCH Study in Adult Females With CelluliteCompletedNCT04170296Phase 3Results posted
• Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFPCompletedNCT03675685Phase 1Results posted
• Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)CompletedNCT03632993Phase 2Results posted
• Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)CompletedNCT03526549Phase 3Results posted
• Effectiveness and Safety of EN3835 in the Treatment of Cellulite in WomenCompletedNCT03446781Phase 3Results posted
• Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in WomenCompletedNCT03428750Phase 3Results posted
• Safety and Effectiveness of EN3835 in the Treatment of EFP in WomenCompletedNCT03329989Phase 2Results posted
• Clostridium Histolyticum Collagenase Injection for Urethral DiseaseCompletedNCT02948842Phase 2Results posted
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT02942160Phase 2Results posted
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT02724644Phase 2Results posted
• Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure UlcersTerminatedNCT02718625Phase 4Results posted
• Use of Santyl in Diabetic Foot UlcersCompletedNCT02581488Phase 4Results posted
• Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of LipomaCompletedNCT02249052Phase 2Results posted
• Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease NodulesCompletedNCT02193828Phase 2Results posted
• Clinical Study for the Treatment of Adhesive Capsulitis of the ShoulderCompletedNCT02006719Phase 2Results posted
• A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic PanniculopathyCompletedNCT01987986Phase 2Results posted
• A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's DiseaseCompletedNCT01685437Phase 3Results posted
• Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's ContracturesCompletedNCT01674634Phase 3Results posted
• A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of LipomaCompletedNCT01613313Phase 2Results posted
• Collagenase Option for Reduction of Dupuytren's Contracture in JapanCompletedNCT01588353Phase 3Results posted
• Retreatment of Recurrent Dupuytren's ContracturesCompletedNCT01498640Phase 4Results posted
• AA4500 for the Treatment of Adhesive Capsulitis of the ShoulderCompletedNCT01483963Phase 2Results posted
• MRI Results in Dupuytren's Contracture Before and After Injection With XiaflexCompletedNCT01450397Phase 4Results posted
• Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's DiseaseCompletedNCT01430169Phase 2Results posted
• Using Santyl on Diabetic Foot UlcersCompletedNCT01408277Phase 4Results posted
• Administration of Two Injections for Multiple Dupuytren's ContracturesCompletedNCT01407068Phase 3Results posted
• Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the ThumbCompletedNCT01265420Phase 4Results posted
• A Study of AA4500 in Men With Peyronie's DiseaseCompletedNCT01243411Phase 3Results posted
• Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)CompletedNCT01229436Phase 3Results posted
• Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's ContractureTerminatedNCT01226121Phase 4Results posted
• Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221623Phase 3Results posted
• Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221597Phase 3Results posted
• Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot UlcersCompletedNCT01143727Phase 4Results posted
• A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot UlcersCompletedNCT01143714Phase 4Results posted
• Santyl vs. Sharp Debridement of Diabetic Foot WoundsCompletedNCT01056198Phase 4Results posted
• The Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseCompletedNCT00755222Phase 2Results posted
• Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedNCT00533273Phase 3Results posted
• A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's ContractureCompletedNCT00528931Phase 1Results posted
• Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedNCT00528840Phase 3Results posted
• AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's ContractureCompletedNCT00528606Phase 3Results posted
• AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseCompletedNCT00528424Phase 3Results posted
• Collagenase in the Treatment of Dupuytrens DiseaseCompletedNCT00260429Phase 3Results posted
• Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's DiseaseActive, not recruitingNCT06649539Phase 4
• A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)CompletedNCT06169319Phase 2
• Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)CompletedNCT06151197Phase 3
• Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's DiseaseActive, not recruitingNCT05777031Phase 4
• Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile DysfunctionWithdrawnNCT05646602Not applicable
• Effect of Oral TXA on Buttock Bruising Post CCH Injections in Adult FemalesCompletedNCT05309525Phase 4
• Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar FibromatosisCompletedNCT05254457Phase 3
• Efficacy of a Novel CCH Protocol for PD Among Prior Non-respondersCompletedNCT05108558Phase 4
• Effectiveness of Splinting After Collagenase InjectionCompletedNCT04874870Phase 3
• Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie'sActive, not recruitingNCT04786106Phase 4
• Xiaflex® Plus Testosterone Treatment Pilot Study ProtocolCompletedNCT03815331Phase 4
• Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete ResponseStatus unknownNCT03767452Phase 4
• Fasciectomy vs Collagenase Injection in Recurrent Dupuytren DiseaseActive, not recruitingNCT03406338Phase 4
• Trial Comparing Treatment Strategies in Dupuytren's ContractureActive, not recruitingNCT03192020Phase 4
• Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's DiseaseStatus unknownNCT03000114Phase 4
• Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)CompletedNCT02889848Phase 1
• Use of Santyl Within an Accountable Care OrganizationWithdrawnNCT02716519Phase 4
• Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNFCompletedNCT02647619Phase 4
• Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's ContractureCompletedNCT01538017Not applicable
• The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT01518907Phase 1
• Injectable Collagenase For Burns' Associated ContractureStatus unknownNCT01237964Phase 2

← Microbial Collagenase overview